Biotech

All Articles

8 months after a $213M fundraise, gene editor Volume creates cuts

.After increasing $213 thousand in 2023-- among the year's largest personal biotech shots-- Tome Bio...

BioMarin constructs exec team with biotech veterinarians-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable management hirings, firings as wel...

Biopharma Q2 VC struck highest degree considering that '22, while M&ampA decreased

.Venture capital funding in to biopharma rose to $9.2 billion throughout 215 deals in the second fou...

Bicara, Zenas find IPOs to press late-phase possessions toward market

.Bicara Rehabs and Zenas Biopharma have provided fresh catalyst to the IPO market with filings that ...

Genentech to finalize cancer cells immunology research study team

.Genentech will certainly close its cancer immunology study division, and also system head and also ...

Kezar falls strong lump however to show its well worth in phase 1 test

.Kezar Life Sciences is actually losing its own unpromising phase 1 strong cyst drug as the biotech ...

Acelyrin loses izokibep, lets go 3rd of personnel

.Despite izokibep keeping its newly found winning streak in the facility, Acelyrin is actually no lo...

Rivus' phase 2 obesity-related heart failure test reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing medi...

Ovid stops preclinical job, IV system after soticlestat neglect

.Ovid Therapeutics currently revealed final month that it was trimming back its own head count as th...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has actually opened up a $700 million R&ampD center in the Boston ma Port, boosting its R...